TriSalus Life Sciences, Inc. (TLSI)
NASDAQ: TLSI · Real-Time Price · USD
7.06
+0.36 (5.37%)
At close: Dec 5, 2025, 4:00 PM EST
7.20
+0.14 (1.98%)
After-hours: Dec 5, 2025, 6:57 PM EST
TriSalus Life Sciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Cash & Equivalents | 22.69 | 8.53 | 11.78 | 9.41 | 30.3 | 4.49 |
| Cash & Short-Term Investments | 22.69 | 8.53 | 11.78 | 9.41 | 30.3 | 4.49 |
| Cash Growth | 100.98% | -27.61% | 25.10% | -68.93% | 575.16% | - |
| Receivables | 5 | 5.09 | 3.55 | 1.56 | 1.36 | 0.62 |
| Inventory | 3.28 | 4.05 | 2.55 | 1.47 | 1.29 | 0.57 |
| Prepaid Expenses | 2.37 | 3.01 | 2.99 | 4.77 | 2.18 | - |
| Other Current Assets | - | - | - | - | - | 0.41 |
| Total Current Assets | 33.33 | 20.67 | 20.86 | 17.21 | 35.13 | 6.08 |
| Property, Plant & Equipment | 2.72 | 2.88 | 3.27 | 3.61 | 1.8 | 1.26 |
| Other Intangible Assets | - | - | - | 0.8 | 0.79 | 0.74 |
| Other Long-Term Assets | 0.42 | 0.42 | 0.47 | 0.37 | 0.12 | 0.05 |
| Total Assets | 36.46 | 23.97 | 24.6 | 22 | 37.84 | 8.13 |
| Accounts Payable | 3.78 | 2.27 | 3.39 | 4.95 | 1.3 | 0.61 |
| Accrued Expenses | 6.77 | 7.32 | 10.53 | 6.38 | 4.97 | 6.73 |
| Current Portion of Long-Term Debt | - | - | - | - | - | 42.18 |
| Current Portion of Leases | 0.13 | 0.22 | 0.35 | 0.37 | - | - |
| Current Income Taxes Payable | - | 0.03 | 0.03 | - | - | - |
| Other Current Liabilities | 0.22 | 0.38 | 0.39 | 20.66 | 0.1 | 5.22 |
| Total Current Liabilities | 10.91 | 10.23 | 14.69 | 32.36 | 6.37 | 54.75 |
| Long-Term Debt | 32.76 | 22.08 | - | - | - | - |
| Long-Term Leases | 1.23 | 1.33 | 1.24 | 1.59 | - | - |
| Other Long-Term Liabilities | 18.28 | 16.22 | 35.73 | 0.37 | 0.56 | 3.54 |
| Total Liabilities | 63.19 | 49.87 | 51.66 | 34.32 | 6.93 | 58.29 |
| Common Stock | 0 | 0 | 0 | - | 0.01 | 0.01 |
| Additional Paid-In Capital | 294.24 | 253.65 | 222.44 | 10.03 | 6.73 | 1.36 |
| Retained Earnings | -320.97 | -279.55 | -249.5 | -186.36 | -136.34 | -107.5 |
| Total Common Equity | -26.73 | -25.89 | -27.07 | -176.33 | -129.6 | -106.13 |
| Shareholders' Equity | -26.73 | -25.89 | -27.07 | -12.32 | 30.9 | -50.16 |
| Total Liabilities & Equity | 36.46 | 23.97 | 24.6 | 22 | 37.84 | 8.13 |
| Total Debt | 34.12 | 23.63 | 1.6 | 1.96 | - | 42.18 |
| Net Cash (Debt) | -11.44 | -15.1 | 10.18 | 7.45 | 30.3 | -37.7 |
| Net Cash Growth | - | - | 36.65% | -75.41% | - | - |
| Net Cash Per Share | -0.35 | -0.60 | 1.08 | 24.07 | 3.42 | -4.91 |
| Filing Date Shares Outstanding | 49.96 | 32.27 | 26.76 | 14.08 | 12.96 | 7.67 |
| Total Common Shares Outstanding | 49.89 | 31.28 | 26.41 | 14.08 | 10.72 | 7.67 |
| Working Capital | 22.42 | 10.44 | 6.18 | -15.14 | 28.76 | -48.67 |
| Book Value Per Share | -0.54 | -0.83 | -1.02 | -12.53 | -12.09 | -13.83 |
| Tangible Book Value | -26.73 | -25.89 | -27.07 | -177.13 | -130.4 | -106.87 |
| Tangible Book Value Per Share | -0.54 | -0.83 | -1.02 | -12.58 | -12.16 | -13.93 |
| Machinery | - | 4.34 | 3.8 | 3.87 | 3.15 | 2.36 |
| Construction In Progress | - | 0.33 | 0.6 | - | - | - |
| Leasehold Improvements | - | 0.77 | 0.77 | 0.77 | 0.78 | 0.68 |
Source: S&P Capital IQ. Standard template. Financial Sources.